Medidata Solutions Further Extends Support for Industry Standards with Medidata Standards Accelerator
Medidata Solutions announced its latest services offering, Medidata Standards AcceleratorTM, which provides end-to-end support for the Clinical Data Interchange Standards Consortium (CDISC) study data tabulation model (SDTM)–the FDA’s recommended format for electronic submission of case report form data. With this offering, Medidata enables sponsors to satisfy FDA submission guidelines in a repeatable fashion, while reducing time and costs.
Medidata’s services team works with sponsors using the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) platform throughout the study lifecycle to streamline the preparation of SDTM-ready data and the export of SDTM-compliant datasets. In addition to the best practices utilized by Medidata services professionals, Standards Accelerator includes multiple tools aimed at streamlining the preparation of SDTM-compliant data sets:
- Pre-built CDASH forms for 17 standard SDTM domains;
- Rave dictionaries using CDISC-controlled terminology;
- Edit checks for SDTM validation rules to minimize data errors.
A longtime CDISC Corporate Sponsor and Registered Solution Provider, Medidata has had a number of its executives formally recognized by CDISC for their individual contributions to standard definitions and ongoing participation in standard groups. Additionally, Rave was the first to be software product certified on all eight Operational Data Model (ODM) use-cases for full interoperability and sharing of clinical data. Rave also was the first EDC solution to provide clinical data acquisition standards harmonization (CDASH) metadata. Medidata Designer®, a study protocol and design solution, has contributed its model to CDISC’s protocol representation model.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
